Venture Planning Group, Sep 2011, Pages: 250
pertaining to the Japanese blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
Venture Planning Group, Jan 2012, Pages: 250
to the Japanese blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Five- and ten-year volume
Venture Planning Group, April 2012, Pages: 250
, including:
- Major issues pertaining to the French hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
Venture Planning Group, April 2012, Pages: 250
, including:
Major issues pertaining to the Italian hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
Venture Planning Group, April 2012, Pages: 250
, including:
Major issues pertaining to the Japanese blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
Venture Planning Group, April 2012, Pages: 255
, including:
Major issues pertaining to the Spanish hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
Venture Planning Group, Feb 2012, Pages: 700
emerging opportunities in the hematology and flow cytometry markets during the next ten years. The report explores future marketing and technological trends in seven countries; provides market share
Venture Planning Group, April 2012
, including:
- Major issues pertaining to the German hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact
Venture Planning Group, April 2012, Pages: 250
:
Major issues pertaining to the UK hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
Venture Planning Group, April 2012, Pages: 275
:
Major issues pertaining to the US hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next
Venture Planning Group, April 2012, Pages: 700
opportunities in the hematology and flow cytometry markets during the next ten years. The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume